167 related articles for article (PubMed ID: 38516785)
1. Cost-effectiveness of active tuberculosis screening among high-risk populations in low tuberculosis incidence countries: a systematic review, 2008 to 2023.
Gogichadze N; Sagrera A; Vicente JÁ; Millet JP; López-Seguí F; Vilaplana C
Euro Surveill; 2024 Mar; 29(12):. PubMed ID: 38516785
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost effectiveness of screening immigrants schemes for tuberculosis (TB) on arrival from high TB endemic countries to low TB prevalent countries.
Sanneh AF; Al-Shareef AM
Afr Health Sci; 2014 Sep; 14(3):663-71. PubMed ID: 25352886
[TBL] [Abstract][Full Text] [Related]
4. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of cost and cost-effectiveness of different TB-screening strategies.
Nienhaus A; Schablon A; Costa JT; Diel R
BMC Health Serv Res; 2011 Sep; 11():247. PubMed ID: 21961888
[TBL] [Abstract][Full Text] [Related]
6. Target prioritization and strategy selection for active case-finding of pulmonary tuberculosis: a tool to support country-level project planning.
Nishikiori N; Van Weezenbeek C
BMC Public Health; 2013 Feb; 13():97. PubMed ID: 23374118
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
Kowada A; Takasaki J; Kobayashi N
J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
[TBL] [Abstract][Full Text] [Related]
8. Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.
Diel R; Lampenius N; Nienhaus A
Pharmacoeconomics; 2015 Aug; 33(8):783-809. PubMed ID: 25774015
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of screening algorithms to identify persons with active pulmonary tuberculosis at prison entry: protocol of a systematic review and network meta-analysis.
Pape S; Gulma K; Shivalli S; Cleenewerck de Kiev L
J Med Life; 2022 Dec; 15(12):1464-1475. PubMed ID: 36762336
[TBL] [Abstract][Full Text] [Related]
10. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.
Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K
BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555
[TBL] [Abstract][Full Text] [Related]
11. Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment.
Yoopetch P; Chitpim N; Jittikoon J; Udomsinprasert W; Thavorncharoensap M; Youngkong S; Praditsitthikorn N; Mahasirimongkol S; Chaikledkaew U
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294107
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.
Schwartzman K; Menzies D
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):780-9. PubMed ID: 10712322
[TBL] [Abstract][Full Text] [Related]
13. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.
Pareek M; Bond M; Shorey J; Seneviratne S; Guy M; White P; Lalvani A; Kon OM
Thorax; 2013 Mar; 68(3):230-9. PubMed ID: 22693179
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of adding tuberculosis household contact investigation on passive case-finding strategy in Southwestern Uganda.
Odongo D; Omech B; Acanga A
PLoS One; 2023; 18(12):e0288761. PubMed ID: 38127969
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review.
Alsdurf H; Empringham B; Miller C; Zwerling A
BMC Infect Dis; 2021 Sep; 21(1):935. PubMed ID: 34496804
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis screening of travelers to higher-incidence countries: a cost-effectiveness analysis.
Tan M; Menzies D; Schwartzman K
BMC Public Health; 2008 Jun; 8():201. PubMed ID: 18534007
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review.
Heuvelings CC; Greve PF; de Vries SG; Visser BJ; Bélard S; Janssen S; Cremers AL; Spijker R; Shaw E; Hill RA; Zumla A; Sandgren A; van der Werf MJ; Grobusch MP
BMJ Open; 2018 Sep; 8(9):e019642. PubMed ID: 30196265
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes.
Kowada A
Epidemiol Infect; 2016 Nov; 144(15):3215-3225. PubMed ID: 27412626
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
